CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 57 enrolled
Drug / intervention
MedViewer reportdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04232540
NCT04232540N/ACompleted
CompareCT.gov

Establishing Novel Antiretroviral Imaging for Hair to Elucidate Non-Adherence (ENLIGHTEN)

University of North Carolina, Chapel Hill·interventional·Posted Jan 18, 2020·Updated Oct 12, 2022

In Brief

A clinical study evaluating MedViewer report for Medication Adherence. Completed, enrolled 57 participants across 1 site.

Detailed Summary

This is a pilot study to assess the feasibility, acceptability and appropriateness of delivery of the investigational "MedViewer" intervention in adult patients living with HIV who have been prescribed antiretroviral (ARV) medications. The Medviewer uses Infra-red (IR) matrix-assisted laser desorption electrospray ionization (MALDESI) technology for mass spectrometry imaging (MSI) to analyze patient hair samples to provide information on ARV adherence in real-time. The study has two different groups of participants: the patients, and their clinician providers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMedication Adherence
CountriesUnited States
CollaboratorsNational Institute of Allergy and Infectious Diseases (NIAID)

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 18, 2020
Enrollment StartJan 14, 2020
Primary CompletionNov 15, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.5 years ago

Interventions

MedViewer reportdevice

Results from the analysis of hair samples performed using the MedViewer